A double-blind, randomized, placebo-controlled study to evaluate the safety and efficacy of 75 mg and 150 mg doses of ERB-041 [prinaberel] on the reduction of symptoms associated with endometriosis during treatment and post treatment in reproductive-aged women
Latest Information Update: 02 Jun 2011
At a glance
- Drugs Prinaberel (Primary)
- Indications Endometriosis
- Focus Therapeutic Use
- 08 Dec 2006 Status change
- 03 Nov 2006 New trial record.